{"id":"W2025360041","doi":"10.1016/j.cgh.2009.03.033","title":"Treatment Options for Patients With Chronic Hepatitis C Not Responding to Initial Antiviral Therapy","year":2009,"lang":"en","type":"review","venue":"Clinical Gastroenterology and Hepatology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Gilead Sciences; Valeant Pharmaceuticals International; Pfizer","keywords":"Ribavirin; Medicine; Pegylated interferon; Internal medicine; Hepatitis C; Interferon; Alpha interferon; Hepatitis C virus; Interferon alfa; Gastroenterology; Population; Clinical trial; Combination therapy; Immunology; Virus","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003728056,0.0006822798,0.001908986,0.001655121,0.0001999294,0.0005741245,0.0006171492,0.0008019089,0.004180655],"category_scores_gemma":[0.0007510673,0.000185453,0.0005936419,0.001049367,0.0002934092,0.0007940306,0.0003556128,0.001211212,0.0009822114],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002943212,"about_ca_system_score_gemma":0.0004919319,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005379815,"about_ca_topic_score_gemma":0.001589645,"domain_scores_codex":[0.999881,0.0000317275,0.0000269162,0.00001681635,0.00003082234,0.00001263107],"domain_scores_gemma":[0.999693,0.0001795369,0.00007402008,0.000005666493,0.00002861066,0.00001917632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001642038,0.00006420069,0.0002769103,0.01617081,0.0001415601,0.0003443622,0.00003661808,0.0001854606,0.0007997236,0.0006182838,0.01878491,0.962413],"study_design_scores_gemma":[0.0004072837,0.0005439629,0.005125976,0.02552264,0.001651639,0.008824462,0.0002503426,0.0003673605,0.001027514,0.002446276,0.9537671,0.00006541855],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002024845,0.9986777,0.00008344732,0.0002333863,0.0001177122,0.000004203346,0.0000116682,0.00000487137,0.0006646411],"genre_scores_gemma":[0.002301521,0.996356,0.0002870817,0.0003815143,0.0002423951,0.00001156787,0.00003809612,0.000001378295,0.0003804319],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004180655,"threshold_uncertainty_score":0.01398575,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1341388383108521,"score_gpt":0.4731841641855639,"score_spread":0.3390453258747118,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}